Viatris Inc vs Vanguard Value Index Fund ETF — how do they compare? Viatris Inc trades at $17.58 (market cap $19.79B), while Vanguard Value Index Fund ETF trades at $218.54. The key difference: Viatris Inc pays a 2.83% dividend while Vanguard Value Index Fund ETF pays none. Which is the better fit depends on your goals.
| VTRS | VTV | |
|---|---|---|
Market Cap | $19.79B | — |
Sector | Health | — |
52-Week High | $17.39 | $220.51 |
52-Week Low | $8.74 | $175.51 |
Enterprise Value | $32.00B | — |
Dividend Yield | 2.83% | — |
Trailing returns across standard periods
Formed by the combination of Mylan and Pfizer's Upjohn business in 2020, Viatris is one of the world's largest generic drug manufacturers, with a substantial off-patent branded drug portfolio. Its portfolio consists of more than 1,400 molecules with penetration across most of the developed world and in select emerging markets. The company's branded drug portfolio consists of off-patent blockbuster drugs that continue to generate strong sales, including Lipitor, Norvasc, Lyrica, Viagra, and EpiPen. While global competition has facilitated the commodification of small-molecule generic drugs, the company has demonstrated an edge over peers in its ability to manufacture complex generics (for example, generic Advair and Copaxone).
Read more on VTRS →The fund employs an indexing investment approach designed to track the performance of the CRSP US Large Cap Value Index, a broadly diversified index predominantly made up of value stocks of large US companies. The advisor attempts to replicate the target index by investing all, or substantially all, of its assets in the stocks that make up the index, holding each stock in approximately the same proportion as its weighting in the index.
Read more on VTV →